National Institutes of Health to Grant Exclusive Patent License to Nova Therapeutics for Thyroid Cancer Diagnosis and Treatment

Summary

The National Institutes of Health is considering a Start-Up Exclusive Patent License to Nova Therapeutics, a Delaware-based company, to use compounds covered by patent rights for human thyroid cancer diagnosis requiring FDA premarket approval and treatment of human thyroid cancer.